Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
683
Frequently Asked Questions
What is Market Cap of Axsome Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Axsome Therapeutics Inc market cap is $6.25B.
What is the 52-week high for Axsome Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Axsome Therapeutics Inc 52 week high is $139.13 as of September 08, 2025.
What is the 52-week low for Axsome Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Axsome Therapeutics Inc 52 week low is $75.56 as of September 08, 2025.
What is Axsome Therapeutics Inc stock price today?
Axsome Therapeutics Inc stock price today is $129.29.
What was Axsome Therapeutics Inc stock price yesterday?
Axsome Therapeutics Inc stock price yesterday was $125.17.
What is the PE ratio of Axsome Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Axsome Therapeutics Inc’s P/E ratio is -24.68.
What is the Price-to-Book ratio of Axsome Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Axsome Therapeutics Inc P/B ratio is 85.3284.
What is the 50-day moving average of Axsome Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Axsome Therapeutics Inc 50-day moving average is $109.81.
How many employess does Axsome Therapeutics Inc has?